Got Wrinkles?
Consider a clinical research study for upper facial lines
You must be:
- 18 years of age or older (men and women of all ethnicities)
- In general good health, with no history of any medical condition that may place you at increased study risk
- Willing to complete in-clinic visits, exams, activities and procedures
- At least 6 months past any prior botulinum neurotoxin treatment as of Study Day 1
- At least 3 to 18 months past certain other cosmetic procedures or treatments, including but not limited to dermabrasion, peels, permanent makeup, non-permanent HA fillers and energy-based facial treatments
- Have no history of treatments to the mid or upper face such as radiation, surgery, suspension threads, non-HA fillers, synthetic implants or fat transplantation
- Not pregnant or breastfeeding
- Able to meet all other eligibility requirements
You may qualify if you have moderate to severe:
Crow’s feet (lateral canthal lines), Forehead lines, and Frown lines (glabellar lines)
Participants will receive:
Study treatment with Botulinum Type A, related exams and follow-up.
About this study:
The M22-974 clinical trial is a prospective, multi-centre, open-label study to evaluate satisfaction and outcomes following administration of Botulinum Toxin Type A in subjects with upper facial lines (glabellar lines, lateral canthal lines and forehead lines).
For more information, please call (905) 850-4415 OR complete an online form and someone from Bertucci MedSpa will contact you.